These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 3969176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome.
    Haisma HJ, Constantinou E, Chinyanga HM.
    Cent Afr J Med; 1990 May; 36(5):141-3. PubMed ID: 2261628
    [Abstract] [Full Text] [Related]

  • 10. Current concepts. Neuroleptic malignant syndrome.
    Guzé BH, Baxter LR.
    N Engl J Med; 1985 Jul 18; 313(3):163-6. PubMed ID: 3892294
    [No Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome (a case report).
    Patkar AA, Shah LP.
    J Postgrad Med; 1991 Jul 18; 37(3):168-70. PubMed ID: 1784031
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Granato JE, Stern BJ, Ringel A, Karim AH, Krumholz A, Coyle J, Adler S.
    Ann Neurol; 1983 Jul 18; 14(1):89-90. PubMed ID: 6614876
    [Abstract] [Full Text] [Related]

  • 13. [Protracted recurrent neuroleptic malignant syndrome].
    Delerue O, Destée A.
    Rev Neurol (Paris); 1990 Jul 18; 146(8-9):515-7. PubMed ID: 2237099
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bromocriptine treatment of neuroleptic malignant syndrome.
    Dhib-Jalbut S, Hesselbrock R, Mouradian MM, Means ED.
    J Clin Psychiatry; 1987 Feb 18; 48(2):69-73. PubMed ID: 3804991
    [Abstract] [Full Text] [Related]

  • 18. Dopamine agonists and neuroleptic malignant syndrome.
    Rosse R, Ciolino C.
    Am J Psychiatry; 1985 Feb 18; 142(2):270-1. PubMed ID: 3970258
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome and its successful treatment with bromocriptine--a case report.
    Javed A, Chaudhry HR.
    J Pak Med Assoc; 1991 Jan 18; 41(1):19-20. PubMed ID: 1672170
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.